Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | MPO | P05164 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 3/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11880596 | 0.98 | LMNA (0.57) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL3082587 | 0.94 | CA12 (0.57) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| Phosphonic Acid SCHEMBL10524558 | 0.90 | LMNA (0.50) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL4687773 | 0.88 | CA1 (0.56) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL11251989 | 0.88 | LMNA (0.81) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL11039288 | 0.88 | CA12 (0.61) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL11556907 | 0.88 | TSHR (0.52) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL11039286 | 0.88 | CA12 (0.61) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL11241561 | 0.87 | LMNA (0.79) | LMNAALDH1A1HTTSMN1; SMN2TSHR | |
| SCHEMBL29526121 | 0.84 | HTT (0.65) | LMNAALDH1A1HTTSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798167-A | Preparation method of plant growth regulator and application of plant growth regulator in agriculture | 贵州工业职业技术学院 | 2025-04-11 | — | — | CN | claimed |
| CN-117156877-A | Perovskite solar cell and preparation method thereof | 武汉万度光能研究院有限责任公司 | 2023-12-01 | — | — | CN | claimed |
| US-7635662-B2 | Compound for color-producing composition, and recording material | CHEMIPRO KASEI KAISHA, LTD. (JP) | 2009-12-22 | — | — | US | claimed |
| EP-1773768-A4 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS INC (US) | 2008-08-06 | — | — | EP | claimed |
| CN-100345829-C | Pyrimidyl sulphone amide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2007-10-31 | — | — | CN | claimed |
| JP-2007523865-A | — | — | 2007-08-23 | — | — | JP | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| US-7129235-B2 | Amides useful for treating pain | ABBOTT LABORATORIES (US) | 2006-10-31 | — | — | US | claimed |
| EP-1646621-A2 | NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN | Abbott Laboratories (US) | 2006-04-19 | — | — | EP | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| US-20050080095-A1 | administering a therapeuitcally effective amount of 3'-(trifluoromethyl)-N-{4-[(trifluoromethyl)sulfonyl]phenyl}-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide; antagonists of vanilloid receptor subtype I | ABBVIE INC. | 2005-04-14 | — | — | US | claimed |
| WO-2005007642-A2 | NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN | ABBOTT LABORATORIES (US) | 2005-01-27 | — | — | WO | claimed |
| EP-0661289-B1 | Vinyl carboxamide derivatives as insecticides and acaricides | SYNGENTA PARTICIPATIONS AG (CH) | 2004-03-03 | — | — | EP | claimed |
| CN-1445353-A | Multi-functional quick dissolving filmy cleanser and its manufacturing methods | WHITE CAT CO LTD SHANGHAI (CN) | 2003-10-01 | — | — | CN | claimed |
| EP-0779906-B1 | EPOXY RESIN MIXTURES FOR PREPREGS AND COMPOSITES | SIEMENS AG (DE) | 1998-07-08 | — | — | EP | claimed |
| CN-1038902-C | Hair-care hair-fixing rubbing towel | XI AN THERMOTECHNICAL INST MIN (CN) | 1998-07-01 | — | — | CN | claimed |
| US-5759690-A | PHOSPHORUS MODIFIED, FIRE RETARDANT, CIRCUIT BOARDS | SIEMENS AKTIENGESELLSCHAFT (DE) | 1998-06-02 | — | — | US | claimed |
| EP-0779906-A1 | EPOXY RESIN MIXTURES FOR PREPREGS AND COMPOSITES | SIEMENS AKTIENGESELLSCHAFT (DE) | 1997-06-25 | — | — | EP | claimed |
| WO-1996007686-A1 | EPOXY RESIN MIXTURES FOR PREPREGS AND COMPOSITES | SIEMENS AKTIENGESELLSCHAFT (DE) | 1996-03-14 | — | — | WO | claimed |
| CN-1065992-A | hair beauty care styling mousse silk scarf | XIAN THERMOTECHNICAL INST MINI (CN) | 1992-11-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080095-A1 | administering a therapeuitcally effective amount of 3'-(trifluoromethyl)-N-{4-[(trifluoromethyl)sulfonyl]phenyl}-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide; antagonists of vanilloid receptor subtype I | TRPV1, OPRL1, TRPV6 | LMNA 2257/4885ALDH1A1 843/4885HTT 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.